3 - Aetiology of Carcinogenesis Flashcards

1
Q

Carcinogenesis

A

The process by which normal, healthy cells transform into cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Somatic mutation theory

A
  • Cancers arise from mutations in individual cells, passed on through division
  • Clinically observable cancer is result of accumulating multiple mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mutator phenotype

A

An acquired increase in rate of mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does first mutator acquisition relate to

A
  • Increased cell division
  • Abnormal DNA replication
  • Damaged DNA repair mechanisms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lethal mutation

A

Disruptive in a manner that harms or kills the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Passenger mutation

A

Consequential, no selective advantage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Driver mutations

A

Provides a selective advantage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Multi step process of mutation

A
  • Cancer causing mutations are cumulative but randomly ordered
  • Mutation can occur in any cell at any time
  • Most likely to occur during DNA replication
  • Will only be passed on if cell divides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stepwise mutations

A
  • Results in heterogeneity between tumours in an individual with metastatic disease or within a single tumour
  • Has implications for therapy (one cell with resistance survives treatment then replicates so cancer comes back resistant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of tumours co-opting existing cellular pathways

A
  • VEGF disruption can change angiogenesis
  • P53 disruption can interfere with apoptosis
  • MAPK signalling can impact on tissue invasion, growth signals self-sufficiency AND proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Selective pressures of tumours

A
  • Immune system
  • Tumour suppressor genes
  • Microenvironment (e.g. anaerobic respiration under hypoxia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Feedback loop of cancer

A

Less tumour cell death –> more proliferation –> more rounds of DNA replication –> more chance of passing mutations on –> more opportunity for mutation and instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Proto-oncogenes typically are one of

A
  • Cell division stimulators
  • Differentiation blockers
  • Apoptosis inhibitors
  • Components of signalling pathways
  • Growth factors.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do proto-oncogenes become oncogenes

A

When expressed at increased levels, resulting from either:
- Amplification leading to more copies of the gene
- Translocation to a more active promotor
- Mutation resulting in a fusion protein with oncogene activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many oncogenes currently known

A

> 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of oncogenes

A

MYC and RAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MYC

A
  • Transcription factor
  • Overexpressed/activated in >50% of human cancers
  • Coordinates many cellular processes (e.g. angiogenesis)
  • Proliferative arrest
  • Blocks senescence and differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MYC addiction

A
  • Tumour survival often depends on high MYC
  • Not sufficient alone for carcinogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

RAS

A
  • GTPase signalling proteins
  • 3 RAS genes
  • RAS on/off activity is sped up by regulatory proteins
20
Q

RAS regulatory proteins

A
  • Guanine nucleotide exchange factors (GEF) catalyse exchange of GDP with GTP (RAS “switched on”).
  • GTPase-activating proteins (GAP) catalyse hydrolysis of GTP to GDP (RAS “switched off”).
  • Mutant RAS don’t allow GAP to coordinate hydrolysis (RAS is stuck ‘on’)
21
Q

3 RAS genes

A
  • KRAS, NRAS, HRA
  • RAS mutants are 85% KRAS
22
Q

RAS effects

A
  • Cell survival and growth
  • Transcription
  • Cell cycle progression
  • Cell migration
23
Q

Tumour supressor genes

A
  • “anti-oncogenes”
  • Problem if these are knocked out
  • Often requires both alleles being knocked out
  • Hereditary susceptibility
  • Often have suppressive or regulatory activity
24
Q

Suppressive or regulatory activity of tumour suppressor genes

A
  • Control proliferation
  • Initiate apoptosis if DNA damage is detected
  • Regulate adhesion i.e. stop metastasis
25
Q

Large scale mutations

A
  • Less common, usually happens during mitosis
  • Chromosomal gain/loss (usually lethal)
  • Translocation/duplication/deletion of large fragments
26
Q

Chromosomal gain/loss

A
  • Down syndrome (trisomy 21)
  • Klinefelter syndrome (XXY)
27
Q

Translocation/duplication/deletion of large fragments

A
  • Philadelphia chromosome seen in CML
  • D deletion syndrome seen in retinoblastoma
28
Q

Philadelphia chromosome

A

Translocation between long arms of chromosomes 9 and 22

29
Q

D deletion syndrome

A

Loss of long arm of chromosome 13

30
Q

Small scale mutations

A
  • Point mutations
  • Proteins can still be made
  • Very subtle differences
  • May prevent one particular role
  • Frame shift in reading frame
31
Q

Carcinogenesis causes

A

Endogenous or exogenous (mainly)

32
Q

Endogenous causes

A
  • Spontaneous
  • Random mistakes in DNA replication
  • Chance increases with age
  • Lifetime incidence of many cancers correlates with normal homeostatic cell division rates in that tissue
33
Q

Exogenous causes

A
  • Carcinogens causing cancer
  • Mutagens cause genetic mutation
  • Most carcinogens are mutagenic
34
Q

Three main groups of carcinogens

A
  • Chemical (e.g. alcohol)
  • Radiological (e.g. UV, x-ray)
  • Biological (e.g. viral, bacterial)
35
Q

Mechanisms of action of environmental carcinogens

A
  • Sources of carcinogen vary in their likelihood of causing cancer in broader or more restricted range of tissues
  • Depends on site of exposure
  • Exposure to higher amounts can allow chemical carcinogens to accumulate in other organs in concentration that can cause disease
36
Q

Alcohol

A
  • Increases risk of mouth, pharynx, larynx, oesophagus, bowel, liver, breast cancer
  • Via blood stream, affects many tissues/organs around the body
37
Q

Alcohol mechanisms of causing cancer

A
  • Ethanol -> acetaldehyde by alcohol dehydrogenase (damages DNA & stops cells from repairing)
  • Ethanol may also cause direct tissue damage to cells of mouth/throat
  • Acts as a solvent for other carcinogens (e.g., from smoking);
  • Increases level of hormones such as oestrogen (linked to breast cancer) or insulin.
38
Q

How many annual cases of cancer in Aus are attributable to long term alcohol consumption

A

> 3,200

39
Q

UV radiation

A
  • 99% of non-melanoma skin cancers and 95% of melanoma caused by UV
  • Sources (sun, sunbeds, sun lamps)
  • UVA penetrates into dermis (Genetic damage to cells, photo-ageing, immune-suppression)
  • UVB penetrates into the epidermis (Damages cells, responsible for sunburn -> melanoma)
  • If damage isn’t repaired, cell may grow in uncontrolled way
40
Q

Incidence of cancer due to radiation in Aus

A

> 13,000 new cases & >1,700 deaths annually

41
Q

HPV

A
  • 14 types can cause cancer (16 & 18 cause 70% of cancer)
  • Chronic infection can lead to pre-cancerous lesions
  • Host genome integration leads to higher risk
  • Two HPV proteins strongly associated with cervical cancer
42
Q

Risk factors of HPV

A
  • HPV type
  • Immune status
  • Coinfection (e.g. herpes simplex, chlamydia)
43
Q

Two HPV proteins strongly associated with cervical cancer

A

E6 and E7

44
Q

E6

A

Inhibits p53 (normally induces apoptosis in response to cellular stress inc DNA damage and viral infection)

45
Q

E7

A

Inhibits Rb (normally prevents cell division by blocking transcription factors)

46
Q

Cancer mutational burden

A
  • Different cancer types carry characteristically different levels of mutations
  • Mutational signatures differ across cancer types
  • Some represent different base substitutions evenly, whilst some are remarkably specific.